← 홈

ADC

1,068개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,068개
ADCBiologicFondazione per la Medicina Pers…deruxtecan have preventive …Phase 2

Brigatinib (Brigatinib)

Breast Cancer; Gastrointestinal Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 74.5%임상시험 40상태 ACTIVE
ADCBiologicAstraZenecaderuxtecan (Dato-DXd, Datro…Phase 3

Dato-DXd (Dato-DXd)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 79%임상시험 40상태 RECRUITING
ADCBiologicMirati Therapeutics Inc.biodistributionPhase 3

Adagrasib (Adagrasib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Dynamic Tumor Resistance

#DynamicTumorResistance#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 31.9%임상시험 38상태 RECRUITING
ADCBiologicSanofiPhase 2

Belumosudil (Belumosudil)

Plasma Cell Myeloma Refractory · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 74%임상시험 38상태 RECRUITING
ADCBiologicNYU Langone Healthderuxtecan (T-DXd) (PFS HR&…Phase 2

Elacestrant (Elacestrant)

ER Positive, HER2 Positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+5
임상시험 38상태 RECRUITING
ADCBiologicFondazione per la Medicina Pers…Phase 2

Selpercatinib (Selpercatinib)

Breast Cancer; Gastrointestinal Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 100%임상시험 38상태 ACTIVE
ADCBiologicCelgenePhase 2

CC-220 (CC-220)

Lymphoma · Lymphoma, B-Cell

#LymphomaB-Cell#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 71.4%임상시험 37상태 DISCONTINUED
ADCBiologicBeijing Biostar Pharmaceuticals…Phase 2

Utidelone (Utidelone)

Non-small Cell Lung Cancer Patients with Brain Metastases · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 36상태 RECRUITING
ADCBiologicMirati Therapeutics Inc.Phase 3

Sitravatinib (Sitravatinib)

Clear Cell Renal Cell Carcinoma · Urothelial Carcinoma

#UrothelialCarcinoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 33.3%임상시험 35상태 DISCONTINUED
ADCBiologicIncyte CorporationPhase 1

Parsaclisib (Parsaclisib)

Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma · Ann Arbor Stage II Diffuse Large B-Cell

#AnnArborStageIIDiffuseLargeB-Cel#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 88.1%임상시험 34상태 RECRUITING
ADCBiologicJanssen Research & Development,…Phase 2

Nirogacestat (Nirogacestat)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 57%임상시험 32상태 RECRUITING
ADCBiologicAkesoaxisPhase 3

Platinum chemotherapy (Platinum chemotherapy)

Advanced Non Small Cell Lung Cancer (NSCLC) · Advanced Non Small Cell Lung Cancer (NSC

#AdvancedNonSmallCellLungCancerNS#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 65.1%임상시험 32상태 RECRUITING
ADCBiologicBeOne MedicinesPhase 1

Anticancer Agents (Anticancer Agents)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 0%임상시험 31상태 RECRUITING
ADCBiologicstaleGBG Forschungs GmbHPhase 2

Inavolisib (Inavolisib)

HER2-positive Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 11.5%임상시험 31상태 RECRUITING
ADCBiologicstaleAmgenPhase 2

Intensity-Modulated Radiotherapy (Intensity-Modulated Radiotherapy)

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 38%임상시험 31상태 RECRUITING
ADCBiologicstaleOHSU Knight Cancer InstitutePhase 1

Losartan (Losartan)

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Anatomic Stage IV Breast Cancer AJCC v8 · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
임상시험 31상태 DISCONTINUED
ADCBiologicstaleAbbViePhase 2

Lubricating Eye Drops (Lubricating Eye Drops)

Recurrent Ovarian Cancer; Folate Receptor-Alpha Positive · Recurrent Ovarian Cancer

#RecurrentOvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 0.02%임상시험 31상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

Nanoliposomal Irinotecan (Nanoliposomal Irinotecan)

Biliary Tract Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 5%임상시험 31상태 ACTIVE
ADCBiologicstaleMing-Yuan ChenPhase 3

Neoadjuvant and Adjuvant Immunotherapy (Neoadjuvant and Adjuvant Immunotherapy)

Locally Advanced Head and Neck Squamous Cell Carcinoma · Locally Advanced Head and Neck Squamous

#LocallyAdvancedHeadandNeckSquamo#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 10%임상시험 31상태 RECRUITING
ADCBiologicstaleNanogen Pharmaceutical Biotechn…Phase 2

Neulasta (Neulasta)

Hodgkin Lymphoma; Anaplastic Large Cell Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 7%임상시험 31상태 ACTIVE

14 / 54 페이지

← 이전다음 →